Liquidia: Capturing Special Situation Gains And Longer-Term Gains [Seeking Alpha]
Liquidia Corporation (LQDA)
Last liquidia corporation earnings: 3/11 07:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Liquidia's launch may go down as one of the most successful drug launches ever. LQDA has stated that 75% of their revenue so far is from PAH prescriptions. Suriphon Singha/iStock via Getty Images The following segment was excerpted from the Arquitos Capital Q4 2025 Investor Letter. Liquidia Corporation ( LQDA Liquidia was our largest contributor in 2025. Shares ended the year at $34.49, increasing from $11.76 at the start of the year. We This article was written by Quick Insights The outcome could impact PH-ILD labeling or require royalties, but with 75% of revenue from PAH, LQDA's core business remains robust even in a worst-case scenario. Management targets $1 billion in 2027 revenue, with Q4 2025 already showing $90 million revenue and $30 million positive free cash flow, suggesting strong operational momentum. LQDA's expansion into larger indications and combination studies with sotatercept could drive significant upside; Merck's M&A activity positions LQDA as
Show less
Read more
Impact Snapshot
Event Time:
LQDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LQDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LQDA alerts
High impacting Liquidia Corporation news events
Weekly update
A roundup of the hottest topics
LQDA
News
- Arquitos Epicus 2025 Shareholder Letter [Seeking Alpha]Seeking Alpha
- Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual CongressGlobeNewswire
- Arquitos Capital Q4 2025 Investor Letter [Seeking Alpha]Seeking Alpha
- Liquidia (NASDAQ:LQDA) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=LQDA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a>MarketBeat
- Laughing Water Capital's Updates on Liquidia Corp (LQDA) [Yahoo! Finance]Yahoo! Finance
LQDA
Earnings
- 11/3/25 - Beat
LQDA
Sec Filings
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- 1/21/26 - Form 4
- LQDA's page on the SEC website